What 6 Analyst Ratings Have To Say About Teladoc Health
Portfolio Pulse from Benzinga Insights
Teladoc Health (NYSE:TDOC) has received 6 analyst ratings in the last quarter, with 2 somewhat bullish and 4 indifferent, and no bullish or bearish ratings. The average 12-month price target among these analysts is $24.17, with a high of $30.00 and a low of $19.00. This target represents a 24.94% decrease from the previous average target of $32.20. Analysts rate stocks based on future earnings potential and company risk, typically updating their ratings quarterly or after significant company events.

November 17, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Teladoc Health has an average analyst price target of $24.17, a decrease of 24.94% from the previous target, with 2 somewhat bullish and 4 indifferent ratings in the last quarter.
The average price target for Teladoc Health has been lowered, which could indicate analysts' reduced confidence in the company's near-term growth potential. However, the lack of bearish ratings suggests that the sentiment is not extremely negative, leading to a neutral short-term impact score. The relevance is high as the article is directly about TDOC's analyst ratings. The importance is significant as price targets can influence investor expectations and stock price, but not at the highest level since there are no extremely negative ratings. The confidence level is set at 80 due to the clear consensus among analysts and the recent update of the price target.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100